ArticleThe Eurasian journal of medicine2026
Nuclear and Mitochondrial DNA Variants in Chiari Malformation Type 1: Insights from an East Coast Malaysian Cohort.
Article in The Eurasian journal of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChiari malformation type 1 (CM1) is a neurological disorder characterized by cerebellar tonsil herniation. While nuclear DNA has been associated with craniovertebral development, the role of mitochondrial DNA (mtDNA) remains unclear. This study investigated nuclear DNA variants (PAX1, EPAS1, DKK1, GDF6) and mtDNA D-loop mutations in CM1 patients from East Coast Malaysia.
methodsSixty-eight participants were enrolled, comprising 38 CM1 patients and 30 controls. Genomic DNA from peripheral blood was analyzed by polymerase chain reaction amplification and Sanger sequencing. Associations between genetic variants and clinicopathological parameters (age, sex, tonsillar herniation, syringomyelia) were assessed using chi-square or Fisher's exact test.
resultsFour nuclear DNA variants were identified, comprising a synonymous PAX1 mutation (c.555G>A, p.K185K) and intronic changes in EPAS1 (c.1035-7C>G), DKK1 (c.548-3T>C), and GDF6 (c.406+112T>C), none of which exhibited significant associations with clinicopathological characteristics. In contrast, mtDNA analysis revealed that 50% of CM1 patients (n = 30) harbored D-loop mutations, predominantly T>C or G>A transitions, including 18 novel variants. Mutation frequency was significantly higher in patients with more severe tonsillar herniation (>10 mm) (OR = 28.570; 95% CI: 3.080-250.000; P < .001) and in those with syringomyelia (OR = 7.792; 95% CI: 1.782-34.060; P = .007), while no significant associations were observed with age or sex.
conclusionNuclear DNA variants may function as genetic modifiers without significant clinical impact. Conversely, mtDNA D-loop mutations were prevalent and correlated with disease severity, suggesting a contributory role in CM1 pathogenesis and warranting further investigation of mitochondrial genetic factors. Cite this article as: Rosdi SNM, Mohamed Yusoff AA. Nuclear and mitochondrial DNA variants in Chiari malformation type 1: insights from an east coast Malaysian cohort. Eurasian J Med. 2026, 58(4), 1209, doi: 10.5152/eurasianjmed.2026.251209.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.